Published in World J Urol on September 29, 2007
Korean clinical practice guideline for benign prostatic hyperplasia. Investig Clin Urol (2016) 0.87
Efficacy of propiverine ER with or without α-blockers related to maximum urinary flow rate in adult men with OAB: results of a 12-week, multicenter, non-interventional study. World J Urol (2011) 0.78
Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review. Semin Intervent Radiol (2016) 0.75
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol (1992) 13.63
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25
The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology (2003) 9.92
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol (2004) 3.72
Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res (2002) 2.66
The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn (2002) 2.46
Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder. BJU Int (2004) 2.11
Incidence rates and risk factors for acute urinary retention: the health professionals followup study. J Urol (1999) 1.58
Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study. J Urol (2003) 1.41
Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol (2005) 1.17
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology (2006) 1.12
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia. J Urol (2004) 1.09
Tamsulosin treatment of 19,365 patients with lower urinary tract symptoms: does co-morbidity alter tolerability? J Urol (1998) 1.01
Does gender or age affect the efficacy and safety of tolterodine? J Urol (2002) 0.94
Low incidence of acute urinary retention in the general male population: the triumph project. Eur Urol (2005) 0.90
Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring. Drug Saf (2001) 0.80
Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder? J Urol (2004) 0.79
Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol (2007) 3.61
Genetics of swarming motility in Salmonella enterica serovar typhimurium: critical role for lipopolysaccharide. J Bacteriol (2000) 2.63
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). J Clin Oncol (2004) 2.07
Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer (1986) 1.95
Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. Urology (2001) 1.92
Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project. Eur Urol (2002) 1.91
Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol (1999) 1.88
Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation (1998) 1.64
Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention. Urology (2000) 1.61
Laparoscopist's thumb: an occupational hazard. Arch Surg (1993) 1.58
Effects of sildenafil on cAMP and cGMP levels in isolated human cavernous and cardiac tissue. Urology (2000) 1.50
The "music" of core-shell spheres and hollow capsules: influence of the architecture on the mechanical properties at the nanoscale. Nano Lett (2008) 1.49
Multidisciplinary approach in the long-term management of intrahepatic stones: Indian experience. Indian J Gastroenterol (2005) 1.48
Single potential analysis of cavernous electrical activity in spinal cord injury patients. J Urol (1994) 1.43
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia. World J Urol (2009) 1.43
Uncircumcision: a historical review of preputial restoration. Plast Reconstr Surg (1998) 1.43
Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate. J Urol (2001) 1.41
The effect of rotational malalignment on X-rays of the wrist. J Hand Surg Eur Vol (2009) 1.41
Hepatic cryosurgery: biological and clinical considerations. J R Coll Surg Edinb (1992) 1.40
The portrait of James Israel by the German impressionist Max Liebermann: a selected pictorial view on the early twentieth century development of surgical urology in Berlin. World J Urol (2001) 1.37
Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest (1992) 1.28
Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem (1990) 1.26
Effects of the nitric oxide synthase inhibitor NG-nitro-L-arginine on the erectile response to cavernous nerve stimulation in the rabbit. Acta Physiol Scand (1991) 1.24
CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit? Indian J Gastroenterol (2009) 1.24
Case report: gastroduodenal intussusception of a gastrointestinal stromal tumour. Br J Radiol (2002) 1.24
Quantitation of DNA extracted after micropreparation of cells from frozen and formalin-fixed tissue sections. Am J Pathol (2000) 1.18
Pulmonary neoplasia among Dresden asbestos workers. Ann N Y Acad Sci (1965) 1.18
Activation of human peripheral monocytes by angiotensin II. FEBS Lett (1994) 1.16
Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol (1996) 1.11
Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? World J Urol (2007) 1.11
Air cystoscopy: the history of an endoscopic technique from the late 19th century. BJU Int (1999) 1.09
Curiosity in urology? Masturbation injuries. Eur Urol (1980) 1.09
Observation of the Kibble-Zurek scaling law for defect formation in ion crystals. Nat Commun (2013) 1.08
Gastrointestinal microbleeding associated with the use of etodolac, ibuprofen, indomethacin, and naproxen in normal males. J Clin Pharmacol (1984) 1.08
Long-term effectiveness of sacral nerve stimulation for refractory urge incontinence. Eur Urol (2001) 1.06
Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. Am J Pathol (1986) 1.03
Long-term safety, tolerability and efficacy of extended-release tolterodine in the treatment of overactive bladder. Eur Urol (2002) 1.03
Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer (2001) 1.02
Diagnostic approach to patients with cholestatic jaundice. World J Gastroenterol (1999) 1.02
Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res (1999) 1.00
Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence. Int Urol Nephrol (1991) 1.00
Characterization of cyclic nucleotide phosphodiesterase isoenzymes in the human ureter and their functional role in vitro. World J Urol (1994) 0.98
Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside. World J Urol (2001) 0.97
Silicone-silver penile prosthesis: description, operative approach and results. J Urol (1980) 0.97
Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br J Cancer (1988) 0.97
The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int (2002) 0.97
The therapeutic value of adrenalectomy in case of solitary metastatic spread originating from primary renal cell cancer. Eur Urol (2005) 0.96
Port-site tuberculosis after laparoscopy: report of eight cases. Surg Endosc (2003) 0.96
Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol (1997) 0.95
Orchitis following mumps vaccination in an adult. Urol Int (1994) 0.95
The prediction of clinical outcome from transurethral microwave thermotherapy by pressure-flow analysis: a European multicenter study. J Urol (1995) 0.94
Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS). Eur Urol (2005) 0.94
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. II. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urol Res (1996) 0.94
Structural interpretation of site-directed mutagenesis and specificity of the catalytic subunit of protein kinase CK2 using comparative modelling. Protein Eng (1999) 0.93
Relaxation of human ureteral smooth muscle in vitro by modulation of cyclic nucleotide-dependent pathways. Urol Res (2000) 0.93
Minimum effective dose of etodolac for the treatment of rheumatoid arthritis. J Clin Pharmacol (1986) 0.93
An assessment of tumor cell viability after in vitro freezing. Cryobiology (1985) 0.92
Initial clinical experience with the selective phosphodiesterase-I isoenzyme inhibitor vinpocetine in the treatment of urge incontinence and low compliance bladder. World J Urol (2000) 0.92
Transurethral microwave thermotherapy for the treatment of BPH: still a challenger? World J Urol (2006) 0.91
Laparoscopic cholecystectomy in acute cholecystitis. Surg Endosc (2001) 0.91
Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. World J Urol (2003) 0.91
Familial orthostatic tachycardia due to norepinephrine transporter deficiency. Ann N Y Acad Sci (2001) 0.90
Transformation of triclosan by Trametes versicolor and Pycnoporus cinnabarinus. Appl Environ Microbiol (2000) 0.90
Selective pharmacological manipulation of the smooth muscle tissue of the genitourinary tract: a glimpse into the future. BJU Int (1999) 0.90
Possible role of bradykinin and angiotensin II in the regulation of penile erection and detumescence. Urology (2001) 0.90
Internal and external validity of the WHO Well-Being Scale in the elderly general population. Acta Psychiatr Scand (1999) 0.90
The influence of anterior root stimulation (S2) in deafferented spinal cord injury men on cavernous electrical activity. J Urol (1992) 0.89
Effects of various phosphodiesterase-inhibitors, forskolin, and sodium nitroprusside on porcine detrusor smooth muscle tonic responses to muscarinergic stimulation and cyclic nucleotide levels in vitro. Neurourol Urodyn (1996) 0.89
Simultaneous occurrence of structure-directed and particle-resonance-induced phononic gaps in colloidal films. Phys Rev Lett (2008) 0.89
Central effects of sildenafil (Viagra) on auditory selective attention and verbal recognition memory in humans: a study with event-related brain potentials. World J Urol (2001) 0.89
Male lower urinary tract symptoms and related health care seeking in Germany. Eur Urol (2001) 0.88
Functional aspects of vascular tenascin-C expression. J Vasc Res (1995) 0.88
Predictive value of decreased p27Kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Br J Cancer (1999) 0.88
Alpha 2-macroglobulin synthesis in interleukin-6-stimulated human neuronal (SH-SY5Y neuroblastoma) cells. Potential significance for the processing of Alzheimer beta-amyloid precursor protein. FEBS Lett (1991) 0.88
Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Identification and characterization. Urol Res (1996) 0.88
The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol (1998) 0.88
In-vitro matured human macrophages express Alzheimer's beta A4-amyloid precursor protein indicating synthesis in microglial cells. FEBS Lett (1991) 0.88
Male choriocarcinoma of the spleen: a case report. Eur J Surg Oncol (1987) 0.88
Detection of hypoglycemic drugs in human urine using micellar electrokinetic chromatography. Anal Chem (1995) 0.87
Testosterone therapy in the ageing male: what about the prostate? Andrologia (2004) 0.87
A typology of men's sexual attitudes, erectile dysfunction treatment expectations and barriers. Int J Impot Res (2007) 0.87
Chromosome studies in eleven colorectal tumors. Cancer Genet Cytogenet (1990) 0.87
Medical treatment and medical side effects in urinary incontinence in the elderly. World J Urol (1998) 0.87
Dehalogenation of chlorinated hydroxybiphenyls by fungal laccase. Appl Environ Microbiol (2001) 0.87
Rejuvenation in the early 20th century. Andrologia (1998) 0.86
Profile of ocular trauma in Papua New Guinea. Aust N Z J Ophthalmol (1997) 0.86
Expression of E-cadherin in primary prostate cancer: correlation with clinical features. Br J Urol (1998) 0.86
Orthostatic intolerance: a disorder of young women. Obstet Gynecol Surv (2000) 0.86
Intussusception due to ileal metastases from renal cell carcinoma. Trop Gastroenterol (2007) 0.86
[Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results]. Urologe A (2002) 0.85
[Guidelines for German urologists on diagnosis of benign prostate syndrome]. Urologe A (2003) 0.85
Camphor overdosage. Therapeutic considerations. N Y State J Med (1978) 0.85
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer. Oncol Rep (1998) 0.85
p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder. Br J Cancer (1995) 0.85
Silk sutures in the common bile duct. Br Med J (1977) 0.85